Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Bayer refuses to comment on Teva acquisition

Bayer refuses to comment on Teva acquisition

15th January 2008

Pharmaceuticals and animal health product firm Bayer has refused to comment on whether it is considering acquiring Teva Pharmaceutical Industries animal health sector, Thomson Financial has reported.

A spokesman for the group told the news agency he could not comment on the situation but confirmed that in principle, the pharmaceutical group is interested in acquisitions which “make sense”.

Teva Pharmaceutical Industries has said that following a strategic review conducted in 2007, it is considering exploring alternatives for its animal health business as it focuses on its core business.

In company reports, Bayer has reported that its animal health branch regularly looks at acquisition options which could supplement its product range.

Bayer’s most recent newsletter to stockholders revealed that sales during the third quarter of 2007 had grown 4.5 per cent to ?7.8 million (£5.9 million).

The group reported that 2007 figures are likely to set new records.

We currently have 5 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.